Neil P. Dyment
Plus aucun poste en cours
Profil
Neil P.
Dyment worked as a Site Manager at Chemfab Corp.
and as a Senior Consultant at Sivik Global Healthcare LLC (Old).
He also served as the Chief Financial Officer & Senior Vice President at La Petite Academy, Inc. and Noble Environmental Power LLC.
Dyment completed his undergraduate degree at Northeastern University.
Anciens postes connus de Neil P. Dyment
| Sociétés | Poste | Fin |
|---|---|---|
Sivik Global Healthcare LLC (Old)
 Sivik Global Healthcare LLC (Old) Investment ManagersFinance Sivik Global Healthcare LLC, formerly Argus Management LLC, is a New York City-based hedge fund manager founded by former members of Galleon Management. | Corporate Officer/Principal | - |
Noble Environmental Power LLC
 Noble Environmental Power LLC Engineering & ConstructionIndustrial Services Noble Environmental Power LLC operates as a renewable energy company. It designs, builds, and operates wind parks. The company was founded by Charles C. Hinckley and John Quirke in August 2004 and is headquartered in Centerbrook, CT. | Directeur Financier/CFO | - |
Chemfab Corp.
 Chemfab Corp. TextilesProcess Industries Part of Compagnie de Saint-Gobain SA, Chemfab Corp. is an emerging biotechnology company based in Merrimack, NH that aims to accelerate patient access to transformational immunotherapies, addressing several of the most challenging unmet medical needs in cancer. The company focuses on natural killer (NK) cell biology and is leveraging multiple advanced patented technologies, including an induced pluripotent stem cell (iPSC) platform for chimeric antigen receptors (CAR) NK cell therapy, next-generation precision gene-editing to enhance targeting of NK cells, and NK engager multi-functional antibodies. The company's initial product portfolio focuses on both hematological malignancies such as multiple myeloma and solid tumors including hepatocellular carcinoma (HCC) and glioblastoma. HCC is a leading cause of cancer-related death, expected to cause 1 million deaths annually by 2030. Despite advances in immunotherapy, with current treatment options including multi-kinase inhibitors (TKI) and checkpoint inhibitors, life expectancy for patients diagnosed with HCC remains very low. | Corporate Officer/Principal | - |
La Petite Academy, Inc.
 La Petite Academy, Inc. Other Consumer ServicesConsumer Services La Petite Academy, Inc. offers a range of education and care programs for children between six weeks and 12 years of age (infants, toddlers, two year old, preschoolers, kindergartners, and school-age). It also offers before and after school programs, summer and holiday camps, and corporate programs. The company was founded on March 12, 1982 and is headquartered in Chicago, IL. | Directeur Financier/CFO | - |
Formation de Neil P. Dyment
| Northeastern University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
La Petite Academy, Inc.
La Petite Academy, Inc. Other Consumer ServicesConsumer Services La Petite Academy, Inc. offers a range of education and care programs for children between six weeks and 12 years of age (infants, toddlers, two year old, preschoolers, kindergartners, and school-age). It also offers before and after school programs, summer and holiday camps, and corporate programs. The company was founded on March 12, 1982 and is headquartered in Chicago, IL. | Consumer Services |
Noble Environmental Power LLC
Noble Environmental Power LLC Engineering & ConstructionIndustrial Services Noble Environmental Power LLC operates as a renewable energy company. It designs, builds, and operates wind parks. The company was founded by Charles C. Hinckley and John Quirke in August 2004 and is headquartered in Centerbrook, CT. | Industrial Services |
Chemfab Corp.
Chemfab Corp. TextilesProcess Industries Part of Compagnie de Saint-Gobain SA, Chemfab Corp. is an emerging biotechnology company based in Merrimack, NH that aims to accelerate patient access to transformational immunotherapies, addressing several of the most challenging unmet medical needs in cancer. The company focuses on natural killer (NK) cell biology and is leveraging multiple advanced patented technologies, including an induced pluripotent stem cell (iPSC) platform for chimeric antigen receptors (CAR) NK cell therapy, next-generation precision gene-editing to enhance targeting of NK cells, and NK engager multi-functional antibodies. The company's initial product portfolio focuses on both hematological malignancies such as multiple myeloma and solid tumors including hepatocellular carcinoma (HCC) and glioblastoma. HCC is a leading cause of cancer-related death, expected to cause 1 million deaths annually by 2030. Despite advances in immunotherapy, with current treatment options including multi-kinase inhibitors (TKI) and checkpoint inhibitors, life expectancy for patients diagnosed with HCC remains very low. | Process Industries |
Sivik Global Healthcare LLC (Old)
Sivik Global Healthcare LLC (Old) Investment ManagersFinance Sivik Global Healthcare LLC, formerly Argus Management LLC, is a New York City-based hedge fund manager founded by former members of Galleon Management. | Finance |
